THE VERTEX.

Edition of Saturday, June 20, 2026


Analyses & Opinions

See All
Ceasefire Tested: Israeli Strikes Expose Fragile Divide in Lebanon
INTERNATIONAL

Ceasefire Tested: Israeli Strikes Expose Fragile Divide in Lebanon

Israeli air strikes killed several civilians in southern Lebanon despite a ceasefire, highlighting the fragility of the agreement. The incident underscores rising tensions and the risk of escalation in the region.

Ultrasonic Espresso: Brewing Without Heat
TECHNOLOGY

Ultrasonic Espresso: Brewing Without Heat

Scientists have demonstrated that high‑frequency sound can produce espresso‑like coffee without boiling water, cutting energy use by 75 % and opening the door to more sustainable, on‑demand brewing.

The Mirage of a Data Breach: Madison Square Garden’s Stolen Secrets
TECHNOLOGY

The Mirage of a Data Breach: Madison Square Garden’s Stolen Secrets

Hackers have claimed to leak a trove of internal data from Madison Square Garden, raising questions about verification, financial impact, and the broader trend of attacks on critical infrastructure. The incident may accelerate stricter security standards and reshape public trust in digital venues.

A Fragile Truce: Israel, Hezbollah, and the Shadow of Iran
INTERNATIONAL

A Fragile Truce: Israel, Hezbollah, and the Shadow of Iran

The United States announced a ceasefire between Israel and Hezbollah, a fragile pause that could pave the way for diplomatic progress amid ongoing Iranian influence. While the truce offers a brief respite, its durability depends on robust monitoring and broader regional diplomacy.

Washington Ties HIV Aid to Afrikaner Safety, Raising Questions on South Africa’s Health Future
POLITICS

Washington Ties HIV Aid to Afrikaner Safety, Raising Questions on South Africa’s Health Future

The United States has halted its multi‑billion‑dollar HIV programme in South Africa, conditioning future aid on demonstrable protection for the Afrikaner minority. The move threatens health outcomes and highlights the growing politicisation of foreign assistance.

Stalled Promise: The 15‑Year‑Old Ebola Vaccine That Could Turn the Tide
TECHNOLOGY

Stalled Promise: The 15‑Year‑Old Ebola Vaccine That Could Turn the Tide

A 15‑year‑old recombinant vesicular‑stomatitis virus vaccine, shelved after early promise, is now being fast‑tracked to combat a Bundibugyo outbreak in Congo. Its delayed development highlights gaps in global health financing and preparedness.